Source comparison
Best Kisspeptin Dosage for LH Release: Clinical Protocol Comparison
Single IV Bolus (Standard) Kisspeptin-54 1.0 IV 12–15 150–180 Low Gold standard for acute LH stimulation. Highest reproducibility, minimal receptor fatigue Single SC Bolus (Adjusted) 1.5 Subcutaneous 11–14 140–170 Practical alternative to IV. Requires dose adj
This comparison does not assign a generated winner or score.
- Single IV Bolus (Standard)
- Kisspeptin-54
- 1.0
- IV
- 12–15
- 150–180
- Low
- Gold standard for acute LH stimulation. Highest reproducibility, minimal receptor fatigue
- Single SC Bolus (Adjusted)
- 1.5
- Subcutaneous
- 11–14
- 140–170
- Practical alternative to IV. Requires dose adjustment but maintains physiological LH pulse
- High-Dose Single Bolus
- 3.2
- 14–16
- 200+
- Moderate–High
- Marginal LH gain, increased nausea and injection site reactions. Not recommended
- Continuous Low-Dose Infusion
- 0.03/hour
- IV infusion
- 8–12 (sustained)
- 24+ hours
- Very Low
- Mimics endogenous kisspeptin secretion. Optimal for multi-day LH pulsatility research
- Pulsatile SC Protocol
- Kisspeptin-10
- 0.8 q4h
- 9–11 per pulse
- 120–150 per pulse
- Low (if spaced ≥4h)
- Faster clearance allows more frequent dosing. Useful for replicating ultradian LH rhythm
- Threshold Dose (Minimal)
- 0.24
- 6–8
- 90–120
- Produces measurable LH elevation but suboptimal for research requiring robust secretion